Alimera Sciences Inc (ALIM)
3.52
-0.19
(-5.12%)
USD |
NASDAQ |
May 01, 16:00
3.52
0.00 (0.00%)
After-Hours: 16:44
Alimera Sciences Cash from Operations (Quarterly): 3.77M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 3.77M |
| September 30, 2023 | -9.826M |
| June 30, 2023 | -5.996M |
| March 31, 2023 | -2.209M |
| December 31, 2022 | -0.251M |
| September 30, 2022 | -1.913M |
| June 30, 2022 | -1.598M |
| March 31, 2022 | -6.213M |
| December 31, 2021 | -4.683M |
| September 30, 2021 | -2.732M |
| June 30, 2021 | 6.692M |
| March 31, 2021 | -2.501M |
| December 31, 2020 | -0.263M |
| September 30, 2020 | -2.148M |
| June 30, 2020 | -0.33M |
| March 31, 2020 | 0.548M |
| December 31, 2019 | 0.422M |
| September 30, 2019 | -3.898M |
| June 30, 2019 | -0.96M |
| March 31, 2019 | 0.284M |
| December 31, 2018 | 0.66M |
| September 30, 2018 | -3.811M |
| June 30, 2018 | -3.354M |
| March 31, 2018 | -5.048M |
| December 31, 2017 | -1.707M |
| Date | Value |
|---|---|
| September 30, 2017 | -4.174M |
| June 30, 2017 | -2.824M |
| March 31, 2017 | -4.169M |
| December 31, 2016 | -2.403M |
| September 30, 2016 | -8.50M |
| June 30, 2016 | -7.461M |
| March 31, 2016 | -6.735M |
| December 31, 2015 | -8.892M |
| September 30, 2015 | -8.818M |
| June 30, 2015 | -12.95M |
| March 31, 2015 | -14.70M |
| December 31, 2014 | -9.15M |
| September 30, 2014 | -4.953M |
| June 30, 2014 | -3.98M |
| March 31, 2014 | -6.218M |
| December 31, 2013 | -9.728M |
| September 30, 2013 | -8.995M |
| June 30, 2013 | -9.323M |
| March 31, 2013 | -9.775M |
| December 31, 2012 | -6.686M |
| September 30, 2012 | -4.433M |
| June 30, 2012 | -4.651M |
| March 31, 2012 | -5.412M |
| December 31, 2011 | -4.568M |
| September 30, 2011 | -5.572M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-9.826M
Minimum
Sep 2023
6.692M
Maximum
Jun 2021
-1.794M
Average
-1.913M
Median
Sep 2022
Cash from Operations (Quarterly) Benchmarks
| Eli Lilly and Co | -311.90M |
| NovaBay Pharmaceuticals Inc | -0.314M |
| Palatin Technologies Inc | -10.48M |
| iBio Inc | -4.706M |
| Theriva Biologics Inc | -6.541M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.085M |
| Cash from Financing (Quarterly) | -0.078M |
| Free Cash Flow | -89.79M |
| Free Cash Flow Per Share (Quarterly) | 0.0704 |
| Free Cash Flow to Equity (Quarterly) | 3.418M |
| Free Cash Flow to Firm (Quarterly) | 8.448M |
| Free Cash Flow Yield | -102.5% |